PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34873461-6	2021	Triptolide was used to evaluate its specific treatment effects on METTL3 in OSCC cells.	triptolide	0-10	methyltransferase like 3	Mus musculus	66-72	
34873461-14	2021	In conclusion, the new finding of the manuscript is that METTL3 enhances the mRNA stability of SLC7A11 via m6A-mediated binding of IGF2BP2, which thus promotes OSCC progression, and triptolide inhibits OSCC by suppressing METTL3-SLC7A11 axis.	triptolide	182-192	methyltransferase like 3	Mus musculus	222-228	
34873461-15	2021	Triptolide has a potential to be as an effective anti-OSCC drug targeted to METTL3.	triptolide	0-10	methyltransferase like 3	Mus musculus	76-82	
34873461-13	2021	Triptolide inhibited METTL3-mediated SLC7A11 expression, thus suppressing malignancy of OSCC cells.	triptolide	0-10	methyltransferase like 3	Mus musculus	21-27